Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas.
Saved in:
| Title: | Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas. |
|---|---|
| Authors: | Ogino H; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Department of Respiratory Medicine & Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan., Taylor JW; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Department of Neurology.; Helen Diller Family Comprehensive Cancer Center, and., Nejo T; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Gibson D; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Watchmaker PB; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Okada K; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Saijo A; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Department of Respiratory Medicine & Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan., Tedesco MR; Department of Neurology., Shai A; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Division of Neuropathology, Department of Pathology, University of California, San Francisco, San Francisco, California, USA., Wong CM; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Division of Neuropathology, Department of Pathology, University of California, San Francisco, San Francisco, California, USA., Rabbitt JE; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Olin MR; Division of Pediatric Hematology/Oncology, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA., Moertel CL; Division of Pediatric Hematology/Oncology, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA., Nishioka Y; Department of Respiratory Medicine & Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan., Salazar AM; Oncovir Inc., Washington, DC, USA., Molinaro AM; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, and.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Phillips JJ; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, and.; Division of Neuropathology, Department of Pathology, University of California, San Francisco, San Francisco, California, USA., Butowski NA; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, and., Clarke JL; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Department of Neurology.; Helen Diller Family Comprehensive Cancer Center, and., Oberheim Bush NA; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Department of Neurology.; Helen Diller Family Comprehensive Cancer Center, and., Hervey-Jumper SL; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, and., Theodosopoulos P; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Chang SM; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, and., Berger MS; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, and., Okada H; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, and.; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2022 Feb 01; Vol. 132 (3). |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
